Figure 5From: miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expressionERBB2 3′UTR acts as a decoy for miR-125b. MDA-MD-453 and MDA-MB-157 (HER2+, EPOR+, miR-125b+) breast cancer cell lines were transfected with pIRES-ERBB2-3’UTR vector and show increased EPOR mRNA levels at 24 hours. Data were obtained from RT-qPCR experiments performed in triplicate. 18S was used as reference gene.Back to article page